PPARA and obesity disorder: The key bioactive constituents—pinocembrin (modulating PPARα pathway) [58], galangin (exhibiting anti-obesity effects) [59], and alpinetin (ameliorating oxidative stress) [60]—could collectively influence lipid metabolism via PPAR signaling and gut microbiota modulation.